Robin Farmanfarmaian

Robin Farmanfarmaian is a Silicon Valley entrepreneur and professional speaker recognized for her work at the intersection of biotechnology, healthcare, and technology. As CEO and co-founder of ArO, Farmanfarmaian leads innovation in biotech ventures and has contributed to more than 20 early-stage startups in areas such as artificial intelligence-driven drug discovery for cancer treatments targeting p53 and AhR pathways, medical devices including inhaled insulin and sleep apnea solutions, and digital health platforms. Her involvement in these fields positions her as a knowledgeable voice on how technology can transform patient care and scale solutions for widespread impact.

Farmanfarmaian is the author of books including "The Patient as CEO: How Technology Empowers the Healthcare Consumer" and "How AI Can Democratize Healthcare: The Rise in Digital Care," which provide insights into patient empowerment and the democratization of medical advancements. She co-founded Face Touch Aware, an Apple Watch app designed to curb face-touching habits, and serves as an advisor to companies such as MindMaze, which develops brain-computer interface and virtual reality therapies for stroke rehabilitation; Luxsonic Technologies, focused on virtual reality radiology solutions; Alacrity Care, specializing in oncology monitoring; and ConceptVines, which invests in disruptive technology.

As a public speaker, Farmanfarmaian addresses audiences at events including the Home Care Innovation Forum, where she discusses artificial intelligence-powered diagnostics such as voice tests for detecting aphasia and Alzheimer's, as well as advancements from companies like Winterlight Labs and Together by Renee. Through her firm, Robin Starbuck LLC, she specializes in business development and sponsorship strategies for startups. Farmanfarmaian is known for translating complex biotechnological breakthroughs into accessible narratives, establishing her as a key figure in healthcare innovation and medtech.